Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Urinary Tract Infections
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Urinary Tract Infections
    Antibiotic prophylaxis and recurrent urinary tract infection in children - (N Engl J Med)
    TopAbstracts in Urinary Tract Infections 10/20/2009 - (DGNews)
    Prophylactic Cefuroxim Reduces Risk of UTI Within 7 Days After Pelvic Organ Prolapse Surgery: Presented at ICS - (DGDispatch)
    TopAbstracts in Urinary Tract Infections 09/22/2009 - (DGNews)
    Doripenem Proves Noninferior to Levofloxacin in Complicated Urinary Tract Infections: Presented at ICAAC - (DGDispatch)

    News archive

     Recent webcasts/CME - Urinary Tract Infections

    Webcasts/CME archive

     Recent cases - Urinary Tract Infections
      An Adult Case of Urinary Tract Infection with Kingella Kingae: A Case Report
      Value of Ultrasound-Guided Irrigation and Drainage of Refractory Pyocysts in ADPKD
      Iatrogenic Fornix Rupture Caused During Retrograde Manipulation of the Ureter: A Case
      Purple Urine Bag Syndrome

      Cases archive
        




      my personal edition > urinary tract infections > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Norfloxacin Offers Fewer Recurrences of Urinary Tract Infection in Diabetic Women Than Nitrofurantoin or Trimethoprim: Presented at ICAAC/IDSA

      By Maggie Schwarz

      WASHINGTON, DC -- October 30, 2008 -- Diabetic women generally had fewer recurrences of urinary tract infection when treated with norfloxacin compared to trimethoprim or nitrofurantoin, irrespective of treatment duration researchers announced here at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and Infectious Diseases Society of America (IDSA) 46th Annual Meeting.

      A team of Dutch investigators set out to determine whether women with diabetes have lower urinary tract infection recurrence rates when treated with an antibiotic with high tissue penetration (norfloxacin) as compared with antibiotics with low tissue penetration (trimethoprim or nitrofurantoin), explained coinvestigator Ronald P. Stolk, MD, PhD, University Medical Centre Groningen, Groningen, The Netherlands.

      The investigators obtained data from the PHARMO Institute, a Dutch national registration database with pharmacy dispensing data. Case reports from a total of 10,349 women with diabetes were included in the study. All subjects had received a first course of trimethoprim, nitrofurantoin, or norfloxacin between 1999 and 2005.

      Urinary tract infection recurrence rates after treatment with norfloxacin were compared to those following trimethoprim or nitrofurantoin treatment within different treatment duration groups. Recurrence was defined as a second prescription for the above medications or a first prescription with amoxicillin (clavulanic acid), fluoroquinolones, or trimethoprim/sulfamethoxazole between 6 and 30 days after the first course of antibiotics.

      Premenopausal women with diabetes had fewer recurrences when treated with norfloxacin versus trimethoprim or nitrofurantoin for at least 4 days.

      Postmenopausal women with diabetes had fewer recurrences when treated with norfloxacin versus trimethoprim or nitrofurantoin.

      [Presentation title: Treatment of Urinary Tract Infections (UTI) in Women With Diabetes Mellitus (DM); Lower Recurrence Rate With Norfloxacin Compared to Nitrofurantoin or Trimethoprim. Abstract L-613]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send